- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02359747
Analysis of Human Genomic DNA in Embryo's Culture Media
Analysis of Human Genomic DNA in Embryo's Culture Media Targeting on a Single Gene Disease and Point Mutations
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Human fertilized oocytes were individually cultured from Day 1 to Day 3, and from day 3 to days 5/6, in 10 ul medium. A total of 100 samples (50 spent media from Day 3 and 50 from Day 5/6) will be use in the study.
Double-stranded DNA (dsDNA) amplifiability will be evaluated in embryos culture media by quantitative PCR on a multicopy gene target (TBC1D3). Quantification will be made with a standard curve constructed with genomic DNA (with culture media -day 3 and day5-, to take into account media inhibitory effects) TSPY1 amplification will be use to assess the presence of Y chromosome WGA followed by PCR on a single copy gene (MTHFR gene) will be performed on a subset of some samples to monitor the C677T polymorphism (genotyping by sequencing) WGA followed by PCR on a single copy gene (MTHFR) will be also performed on blastocoele fluids
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Simone Palini
- Phone Number: +393394572101
- Email: simonepalini@yahoo.it
Study Locations
-
-
-
Cattolica, Italy, 47841
- Recruiting
- Cervesi Hospital
-
Contact:
- silvia de stefani
- Email: silviadestefani@ymail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria
- all the patients undergoing IVF treatment at Cervesi Hospital
Exclusion Criteria:
- patients with embryos that can't be cultured from day 0 (insemination day) to day 5/6 (blastocyst stage)
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
In Vitro Fertilization treatment
culture medium discarded after IVF treatment
|
Polymerase Chain Reaction and Whole Genome Amplification
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
genomic DNA in culture medium (pg)
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
amplification of point mutation
Time Frame: 1 year
|
amplification of point mutation with PCR (polymerase chain reaction)
|
1 year
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PGD on culture media is easy
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.